Holen Sie sich die Stockscreener-App
23.81
0.00%
0.00
Schlusskurs vom Vortag:
$0.00
Offen:
$19.31
24-Stunden-Volumen:
2.94M
Relative Volume:
1.00
Marktkapitalisierung:
$1.13B
Einnahmen:
Nettoeinkommen (Verlust:
KGV:
-
EPS:
-
Netto-Cashflow:
1W Leistung:
+0.00%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$19.31
$25.00
52-Wochen-Spanne:
$19.31
$25.00
Iambic Therapeutics, Inc. Common Stock Stock (IAM) Company Profile
Firmenname
Iambic Therapeutics, Inc. Common Stock
Sektor
Branche
Telefon
-
Adresse
-
Compare IAM vs VRTX, MRNA, REGN, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IAM
Iambic Therapeutics, Inc. Common Stock
|
23.81 | 1.13B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Iambic Therapeutics, Inc. Common Stock Aktie (IAM) Neueste Nachrichten
Iambic Therapeutics CFO Michael Secora Granted RSUs and Stock Options on October 14, 2026 - Kalkine Media
Form 4 Iambic Therapeutics: Michael Secora (CFO & Chief Corp Dev Ofcr) For: 14 October - Investing.com India
Wilson Sonsini Advises Iambic Therapeutics on $150 Million Initial Public Offering - Wilson Sonsini
Total common shares outstanding of Iambic Therapeutics, Inc. – BOATS:IAM - TradingView
IAM SEC FilingsIambic Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Upcoming and recent IPOs – IPOs calendar - Yahoo Finance Australia
Upcoming & Recent IPO'sIPOs Calendar - Yahoo Finance
Rachlin Evan Lockwood Reports Initial Indirect Ownership in Iambic Therapeutics via Ascenta Capital - Kalkine Media
Iambic Therapeutics prices IPO at $16 per share to raise $150 million - scanx.trade
Iambic Therapeutics prices IPO at $16 per share - Investing.com
Articles from Iambic Therapeutics, Inc. - FinancialContent
Iambic Announces Pricing of Initial Public Offering - Business Wire
Iambic Therapeutics, Inc. has completed an IPO in the amount of $150 million. - www.marketscreener.com
Iambic Therapeutics Files to List Common Stock on Nasdaq Exchange - Kalkine Media
Diluted net income available to common stockholders of IAMBIC THERAPEUTICS INC – NASDAQ:IAM - TradingView
IAMBIC THERAPEUTICS INC Statistics – NASDAQ:IAM - TradingView
NVIDIA-Backed Iambic Therapeutics Files for IPO - Digital Health News
Iambic Therapeutics, Inc. has filed an IPO in the amount of $100 million. - www.marketscreener.com
Finanzdaten der Iambic Therapeutics, Inc. Common Stock-Aktie (IAM)
Es liegen keine Finanzdaten für Iambic Therapeutics, Inc. Common Stock (IAM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
6.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):